![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C12N 15/13 | (2006.01) |
C07K 16/24 | (2006.01) | ||
C12N 15/79 | (2006.01) | ||
C12N 5/10 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/42 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
G01N 33/50 | (2006.01) | ||
G01N 33/577 | (2006.01) |
(11) | Number of the document | 2090657 |
(13) | Kind of document | T |
(96) | European patent application number | 09006396.7 |
Date of filing the European patent application | 2001-08-07 | |
(97) | Date of publication of the European application | 2009-08-19 |
(45) | Date of publication and mention of the grant of the patent | 2017-03-01 |
(46) | Date of publication of the claims translation | 2017-07-25 |
(30) | Number | Date | Country code |
223358 P | 2000-08-07 | US | |
236827 P | 2000-09-29 | US | |
920262 | 2001-08-01 | US |
(72) |
Giles-Komar, Jill, US
Knight, David M., US
Peritt, David, US
Scallon, Bernhard, US
Shealy, David, US
|
(73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas |
Anti-IL-12 antibodies, compositions, methods and uses |
Payment date | Validity (years) | Amount | |
2020-07-24 | 347.00 EUR |